TELO vs W · $86.0M cap vs rev $11.85B
Telomir Pharmaceuticals, Inc. Common Stock (TELO) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Wayfair Inc (W) is a internet retail company listed on NYSE.
TELO does not have a complete income-statement cache yet.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
TELO currently screens at market cap $86.0M. W currently screens at market cap $10.77B.
Not investment advice. Open the TELO and W stock pages for the full models.
Not investment advice.